Primary care management of migraine

Date: 8 July 2021

The recent down-scheduling of some medications in the triptan class to Pharmacist Only medicines has increased the scope of migraine management that pharmacists can offer to patients.

However, triptans are not suitable for all patients, and simple analgesia may be a more appropriate option for some people experiencing a migraine attack.1,2

Determining the most appropriate treatment option requires consideration of patient history, symptom presentation and previous treatment regimen.

Guild Learning and Development is pleased to partner with GSK on the development of an education module on this topic titled ‘Primary care management of migraine’.

This module educates pharmacists on the best-practice management of migraine while focusing on the role of simple analgesia and other non-prescription options for patients.

The inclusion of case studies will help crystalise the role of each available medication class in the management of migraine in community pharmacy.

To enrol in this course please visit guilded.guild.org.au

Please contact Guild Learning and Development on 1800 049 056 or email learninganddevelopment@guild.org.au for more information.

Guild Learning and Development thanks GSKfor its financial support in developing this module.

This activity has been accredited for 0.75 hours of Group 1 CPD (or 0.75 CPD credits), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to 0.75 hours of Group 2 CPD (or 1.5 CPD credits) upon successful completion of relevant assessment activities.

References

  1. Triptans. 2021. In: Australian Medicines Handbook [Internet]. Available from: amh.net.au.
  2. eTG Complete [digital]. Migraine. 2021. Available from: https://www.tg.org.au.

Contact: Peter Waterman
Phone: 0419 260 827

Page last updated on: 16 February 2022